(Q37633387)

21 August 2017

1 reference

title

Epilepsy and neurocysticercosis in sub-Saharan Africa (English)

1 reference

21 August 2017

0 references

1 reference

Andrea Sylvia Winkler

1

1 reference

21 August 2017

Arve Lee Willingham

2

1 reference

21 August 2017

Chummy Sikalizyo Sikasunge

3

1 reference

21 August 2017

Erich Schmutzhard

4

1 reference

21 August 2017

language of work or name

1 reference

1 October 2009

1 reference

21 August 2017

published in

Vienna Clinical Weekly

1 reference

21 August 2017

volume

121 Suppl 3

1 reference

21 August 2017

page(s)

3-12

1 reference

https://scigraph.springernature.com/pub.10.1007/s00508-009-1242-3

21 August 2017

exact match

0 references

cites work

The pattern of epileptic seizures in rural Tanzania.

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Epidemiology and aetiology of epilepsy in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

The epidemiology of epilepsy in Europe - a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Active convulsive epilepsy in a rural district of Kenya: a study of prevalence and possible risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Prevalence of active epilepsy in a rural area in South Tanzania: a door-to-door survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Morbus sacer in Africa: some religious aspects of epilepsy in traditional cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Epilepsy and neurocysticercosis in rural Tanzania-An imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immunologic diagnosis, economics, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Neurocysticercosis in the United States: review of an important emerging infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Control of Taenia solium cysticercosis/taeniosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Neurocysticercosis in an Orthodox Jewish community in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Cysticercosis: imported and autochthonous infections in Kuwait

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Advances in the diagnosis and management of neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Magnitude of the disease burden from neurocysticercosis in a developing country

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Calcific neurocysticercosis and epileptogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Clinical aspects of neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Epidemiologic classification of seizures associated with neurocysticercosis: observations from a sample of seizure disorders in neurologic care in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Cysticercosis and epilepsy: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Calcified cysticercotic lesions and intractable epilepsy: a cross sectional study of 512 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Epilepsy due to neurocysticercosis: analysis of 203 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Headache and cysticercosis in Ecuador, South America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Cysticercosis headache: an important differential of childhood headache disorder in endemic countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Bruns syndrome caused by intraventricular neurocysticercosis treated using flexible endoscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Neurocysticercosis and epilepsy in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Proposed diagnostic criteria for neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Immunodiagnostic tools for human and porcine cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Multiple genotypes of Taenia solium--ramifications for diagnosis, treatment and control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Treatment of neurocysticercosis: current status and future research needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

The current status of neurocysticercosis in Eastern and Southern Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Regional status, epidemiology and impact of Taenia solium cysticercosis in Western and Central Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Neurocysticercosis and epilepsy in Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Neurocysticercosis: a major aetiological factor of late-onset epilepsy in Madagascar

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Seroprevalence of cysticercosis in Bénin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Cysticercosis as a major risk factor for epilepsy in Burundi, east Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

A seroepidemiological study of human cysticercosis in West Cameroon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Prevalence of Taenia solium porcine cysticercosis in the Eastern, Southern and Western provinces of Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Risk factors associated with porcine cysticercosis in selected districts of Eastern and Southern provinces of Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Anticysticercal and antitoxocaral antibodies in people with epilepsy in rural Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Relationship Between Epilepsy and Tropical Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Laboratory diagnosis of human neurocysticercosis: double-blind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Combined use of an antigen and antibody detection enzyme-linked immunosorbent assay for cysticercosis as tools in an epidemiological study of epilepsy in Burundi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Neurocysticercosis: detection of Taenia solium DNA in human cerebrospinal fluid using a semi-nested PCR based on HDP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

A health-education intervention trial to reduce porcine cysticercosis in Mbulu District, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-009-1242-3

Vaccination of pigs to control human neurocysticercosis

21 January 2018

1 reference

12 December 2020

Neurocysticercosis: experience with diagnosis by ELISA serology and computerised tomography in Zimbabwe

1 reference

12 December 2020

Estimations of the prevalence of epilepsy in sub-Saharan Africa

1 reference

12 December 2020

Prevalence of cysticercosis in epileptics and members of their families in Burundi

1 reference

12 December 2020

A proposal to declare neurocysticercosis an international reportable disease

1 reference

12 December 2020

Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients

1 reference

12 December 2020

Epidemiological study of neuro-cysticercosis in northern Togo (West Africa).

1 reference

12 December 2020

Neurocysticercosis: clinical, radiologic, and inflammatory differences between children and adults

1 reference

12 December 2020

The role of the irritative zone and of the number and distribution of calcifications in the severity of epilepsy associated with intracranial calcifications

1 reference

12 December 2020

1 reference

12 December 2020

Brain scans, epilepsy and cerebral cysticercosis

1 reference

12 December 2020

Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico.

1 reference

12 December 2020

Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases.

1 reference

12 December 2020

Neurocysticercosis in children

1 reference

12 December 2020

Seroprevalence of human cysticercosis in Maputo, Mozambique

1 reference

12 December 2020

Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence.

1 reference

12 December 2020

Epilepsy, cysticercosis and neurocysticercosis in Benin.

1 reference

12 December 2020

Neurocysticercosis in the HIV era: a case report and review of the literature.

1 reference

12 December 2020

Relationship between epilepsy and tropical diseases. Commission on Tropical Diseases of the International League Against Epilepsy

1 reference

12 December 2020

Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients

1 reference

12 December 2020

Effective, single-dose treatment or porcine cysticercosis with oxfendazole.

1 reference

12 December 2020

An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium)

1 reference

12 December 2020

Prevalence, incidence, and clinical characteristics of epilepsy--a community-based door-to-door study in northern Tanzania

1 reference

12 December 2020

10.1007/S00508-009-1242-3

Identifiers

DOI

1 reference

21 August 2017

1 reference